Lilly Receives Additional FDA Approval for Verzenio (abemaciclib), as Initial Treatment for Advanced Breast Cancer

Source :: Plus Company Updates. February 27, 2018
Publication Year :: 2018
Abstract: Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved VerzenioTM [...]

Subjects :: United States. Food and Drug Administration
Eli Lilly and Co.
Cancer treatment
Postmenopausal women -- Drug therapy
Pharmaceutical industry
Drug approval
Breast cancer -- Drug therapy
Cancer metastasis -- Drug therapy
General interest
News, opinion and commentary
Verzenio (Medication)

Tools